News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • SPX Technologies was upgraded to Buy to play an HVAC recovery.
  • Shares pulled back to the mid-$150s after a year-to-date decline.
  • Company reported solid Q3 results.
  • Earnings outlook was upgraded.
  • HVAC revenue grew 35% year-over-year.
  • Tactical trade plan: entry $159.25, stop $148.17, target $195 within 45 trading days.

Latest Articles

Buy LULU Here: 43% Upside Even if Americas Stays Soft Through 2030

Buy LULU Here: 43% Upside Even if Americas Stays Soft Through 2030

lululemon trades like a distressed growth stock but still produces strong cash and returns; at a $10.7B market cap the company’s free cash flow and low multiples offer a 43% upside to $132.30 even under a prolonged Americas slowdown. This trade pairs a disciplined entry and stop with a long-term horizon to ride a valuation re-rating or a fundamenta…

Nano Labs: Cheap, Volatile, and Setup For A Catalyst-Driven Bounce

Nano Labs: Cheap, Volatile, and Setup For A Catalyst-Driven Bounce

Nano Labs (NA) is a micro-cap fabless chip designer that reported severe H1 2026 pain but retains a strategic crypto reserve and a product pipeline targeting AI and Web3 convergence. At a $48M market cap and $2.19 stock price, the risk-reward is asymmetric if upcoming operational updates and product rollouts show traction. This is a high-risk, cata…

Adobe Is Priced for Slow Growth — Betting on an Upside Re-rate

Adobe Is Priced for Slow Growth — Betting on an Upside Re-rate

Adobe’s current valuation implies a very low growth trajectory through FY2030. With $10.6B in free cash flow, $24.55B of buyback capacity and AI-driven product upgrades in Creative Cloud and Experience Cloud, the risk-reward favors a long trade. Entry $242.65, target $300.00, stop $215.00; horizon: long term (180 trading days).

Edible Garden Receives Preliminary Approval to Sell Tax Credits Through New Jersey Economic Development Authority (NJEDA) Program

Edible Garden Receives Preliminary Approval to Sell Tax Credits Through New Jersey Economic Development Authority (NJEDA) Program

Edible Garden AG Incorporated announced preliminary approval from the New Jersey Economic Development Authority (NJEDA) to participate in their Tax Certificate Transfer Program, allowing the company to monetize unused net operating losses and R&D tax credits. This program could provide additional non-dilutive capital to support Edible Garden's ongo…

SkinHealth Systems Announces Reverse Stock Split

SkinHealth Systems Announces Reverse Stock Split

SkinHealth Systems (Nasdaq: SKIN), known for its Hydrafacial brand, announced a 1-for-20 reverse stock split effective October 14, 2026. This move aims to comply with Nasdaq’s $1.00 minimum bid price requirement. The split will reduce outstanding shares from approximately 130.3 million to 6.5 million while not affecting total authorized shares. Con…

HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors

HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors

HCW Biologics announced progress towards filing an Investigational New Drug (IND) application in the first half of 2027 for HCW11-018b, their lead candidate in a second-generation non-Fc-based T-Cell Engager Program targeting solid tumors using their proprietary TRBC platform. The company received clear FDA guidance following a Type B meeting, is u…

Microchip Technology Acquires VORAGO Technologies

Microchip Technology Acquires VORAGO Technologies

Microchip Technology Incorporated has acquired VORAGO Technologies, a specialist in radiation-hardened microcontrollers and microprocessors, to strengthen its aerospace and defense market offerings. The acquisition enhances Microchip's product portfolio with VORAGO's patented HARDSIL technology, supporting mission-critical applications in harsh env…

Toro Corp. Reports Net Income of $0.6 Million for the Three Months Ended June 30, 2026, and $1.1 Million for the Six Months Ended June 30, 2026

Toro Corp. Reports Net Income of $0.6 Million for the Three Months Ended June 30, 2026, and $1.1 Million for the Six Months Ended June 30, 2026

Toro Corp., a Nasdaq-listed global energy transportation provider, announced its Q2 and H1 2026 financial results. The company reported a significant increase in vessel revenues driven by higher charter rates and fleet utilization despite a decline in net income and earnings per share compared to the prior year. Strategic developments include the a…

Robin Energy Adds Exposure to the VLCC Segment

Robin Energy Adds Exposure to the VLCC Segment

Robin Energy Ltd., a Nasdaq-listed global energy transportation company, has strategically increased its exposure to the crude tanker sector by participating in a private placement for Volare Shipping Ltd., a newly listed company on Euronext Growth Oslo Børs specializing in Very Large Crude Carriers (VLCCs). This move capitalizes on strong market f…

McEwen Signs US$55 Million Agreement to Sell Fuller and Paymaster

McEwen Signs US$55 Million Agreement to Sell Fuller and Paymaster

McEwen Inc. announced a definitive agreement to sell the Fuller and Paymaster properties in Timmins, Ontario, for US$55 million, partly in Discovery Mining Ltd. common shares and cash. This transaction will help McEwen monetize non-core assets and provide additional capital to fund its operations and development projects, aiming to produce 250,000–…

Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026

Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026

Mineralys Therapeutics announced new analyses from its pivotal Phase 3 Launch-HTN trial showing 46% of difficult-to-treat hypertension patients treated with lorundrostat achieved guideline-recommended systolic blood pressure targets at 12 weeks. Additionally, Phase 2 Explore-OSA trial results showed significant morning systolic blood pressure reduc…